Companies / Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc.

CDTXCIK 1610618SAN DIEGO, CAcidara.com ↗

Financials · FY2024

Revenue$1.27M
Net income$-169.83M
Total debt—
Cash$293.65M
Diluted EPS$-26.75
Shares outstanding31.4M

Ownership

31.4M shares outstanding · as of Nov 3, 2025
6.4%10%+ / strategic
Ownership
10%+ / strategic6.38%2,007,193
Public float93.62%29,432,178

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 16

View all →
Insider% of sharesShares
Bassler Bonnie LDirector
0.00%0
Burgess Daniel DDirector
0.00%0
Davarpanah Nicole NegarChief Medical Officer
0.00%0
Karbe FrankChief Financial Officer
0.00%0
Mineo ChrysaDirector
0.00%0
RA Capital Management, L.P.Director · 10% owner
0.00%0
Stein JeffreyCEOPresident & CEO · Director
0.00%0
Ward ShaneCOO & CLO
0.00%0
Canale-Theakston CarinDirector
——
Kolchinsky PeterDirector · 10% owner
——

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

—View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G—2,007,193—
Point72 Asset Management, L.P.Passive13G/A———
Vivo Opportunity Fund Holdings, L.P.Passive13G/A———
BCLS Fund III Investments, LPPassive13G/A———